Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03570060
Other study ID # GUENANCIA 2017
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2018
Est. completion date April 2025

Study information

Verified date April 2021
Source Centre Hospitalier Universitaire Dijon
Contact Charles GUENANCIA
Phone 0380293535
Email charles.guenancia@chu-dijon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main hypothesis of this work is that an approach combining clinical parameters and biomarker assays could improve the understanding and prediction of the occurrence of silent atrial fibrillation (AF) in the acute phase after stroke. In this prospective work, the investigators will rely on the Dijon Stroke Registry, which collects extensive clinical data for each patient hospitalized for a stroke. As part of this registry, patients are seen 6 months after stroke to assess their clinical status. This clinical follow-up will allow us to judge the evolution of the AF diagnosed during the acute episode at a distance.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient who had an ischemic stroke defined according to WHO criteria and hospitalized in the Stroke Unit at the Dijon University Hospital. - Patient 18 years of age and older - Patient who has given oral consent Exclusion Criteria: - Person not affiliated to a national health insurance scheme - Protected adult - Pregnant or breastfeeding woman - Patient refusing to participate in the study - Transfer planned after the stay in the Stroke Unit to a department outside the Dijon University Hospital, not allowing for the long term screening with an external ECG monitor - History of atrial fibrillation or atrial flutter - Patient wearing a pacemaker or defibrillator with an atrial lead

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Blood sample
2 ml of blood for testing for serum biomarkers (IL-6, GDF-15, soluble ST-2 soluble, osteoprotegerin, galectin 3)
Procedure:
Long term ECG monitor
Fitting and removal of a long term ECG monitor (SpiderFlash, LivaNova)
Monitoring ECG
Recording of automatic ECG monitor results (CSM Philips IntelliVue MP50 system)

Locations

Country Name City State
France CHU Dijon Bourgogne Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnosis of atrial fibrillation during continuous monitoring in a Stroke unit within six months of stroke. 6 months
See also
  Status Clinical Trial Phase
Completed NCT02002390 - Efficacy and Safety of FTY720 for Acute Stroke Phase 2
Completed NCT02523261 - Interest of Direct Aspiration First Pass Technique (ADAPT) for Thrombectomy Revascularisation of Large Vessel Occlusion in Acute Ischaemic Stroke N/A
Withdrawn NCT01985100 - The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke N/A
Completed NCT01934374 - Long-Term Effects of Task-Oriented Lower Extremity Strengthening Training N/A
Completed NCT02466893 - COMPASS Trial: a Direct Aspiration First Pass Technique N/A
Completed NCT02452216 - Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS Early Phase 1
Completed NCT02776540 - Clopidogrel for Acute Ischaemia of Recent Onset Phase 4
Not yet recruiting NCT04205578 - NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Phase 3
Recruiting NCT02900521 - Population-based Brest Stroke Registry
Not yet recruiting NCT02347358 - Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke Phase 2
Not yet recruiting NCT04763161 - Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study